Covid Vaccination Argentina

[gracielle]

4 February 2022 by Usaid Siddiqui

What we know so far about the new Omicron subvariant

Some early studies show the BA.2 subvariant appears to be more transmissible than the original Omicron strain.

www.aljazeera.com

 

[gracielle]

13 February 2022 by Victor Ingrassia

La vitamina D puede reducir el riesgo de padecer un cuadro grave de COVID-19

Nuevos estudios avalan la eficacia de este nutriente para prevenir infecciones respiratorias virales y bacterianas. Expertos explican de qué manera su déficit impacta en la salud

www.infobae.com

Vitamin D can reduce the risk of severe COVID-19. New studies support the efficacy of this nutrient in preventing viral and bacterial respiratory infections. Experts explain how its deficiency impacts on health....The latest study finds that people with vitamin D deficiency are more likely to have a severe or critical case of COVID-19. So say scientists in a new study published in the journal PLOS ONE, which is based on data from the first two waves of coronaviruses in Israel before vaccines became widely available. "Although the study was conducted before the Omicron variant, the coronavirus has not changed sufficiently to negate the efficacy of vitamin D....
My addendum:
Published 3 February 2022

Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness

Objective Studies have demonstrated a potential correlation between low vitamin D status and both an increased risk of infection with SARS-CoV-2 and poorer clinical outcomes. This retrospective study examines if, and to what degree, a relationship exists between pre-infection serum...

journals.plos.org

 

[gracielle]

18 February 2022

Vacuna COVID cuarta dosis en CABA: se aplica en marzo, para quiénes y cómo anotarse

A partir de marzo la Ciudad de Buenos Aires comenzará a aplicar una cuarta dosis de las vacunas contra el Covid-19: ¿A quiénes y cómo acceder?

www.cronista.com

COVID vaccines fourth dose in CABA: to be applied in March, for whom and how to register. It has already been confirmed: the announcement was made this Thursday by the BA Minister of Health, Fernán Quirós. He also explained that for the immunosuppressed, the booster should be applied "periodically" so that the antibodies against Covid-19 "maintain the same effect or the same potency of immunity". Regarding a fourth dose -or second booster- for the general population, its application has not yet been decided by the Gov't, although, according to Quirós, "it is an issue that is being evaluated and the opportunity and form are being considered".

The first to receive a new injection will be those at risk groups with immune system deficiencies:
- Those who are receiving chemotherapy,
- Those who are receiving immunosuppressants for transplants or similar,
- Those who are receiving corticoids,
- Those who are undergoing hemotherapy treatment and,
- Those who have a disease that has damaged their immunity (congenital or acquired, such as HIV).

 

[FrankPintor]

High dose (100,000 UI) Oravil vitamin D3 can be bought in Farmacity, I'd say take it once a month or two months starting in autumn when your body's natural vitamin D production will start declining.

 

[gracielle]

20 February 2022 by Guadalupe Nogués* and Brenda Walter**
*Doctorate in Molecular Biology, teacher and scientific communicator, Fellow of the Bunge y Born Foundation. ** Specialist in non-profit organizations, Bachelor's Degree in Political Science, and Senior Project Coordinator at the Bunge y Born Foundation.

¿Los argentinos confiamos y accedemos a las vacunas?

Un informe que la Fundación Bunge y Born elabora desde 2019 permite evaluar la actitud de la sociedad ante las vacunas, antes y después de la pandemia. El nivel de confianza es alto, pero está descendiendo.

www.perfil.com

Do Argentines trust and have access to vaccines?
A report prepared by the Bunge y Born Foundation since 2019 allows to evaluate the attitude of the society towards vaccines, before and after the pandemic. The level of trust is high, but it is decreasing....

To know more about the report: Index of Confidence and Access to Vaccines (ICAV)

ICAV | Confianza y Acceso a Vacunas | Fundación Bunge y Born

Estudiamos actitudes y opiniones sobre las vacunas, los discursos públicos que se difunden a través de medios de comunicación y redes sociales, y las barreras de acceso a servicios de inmunización en Argentina.

www.fundacionbyb.org

 

[gracielle]

22 February 2022 by María José Lucesole

Covid-19: la provincia anunció que será libre la tercera dosis para todos los mayores de 18 años

Así lo comunicó el gobernador bonaerense Axel Kicillof

www.lanacion.com.ar

The governor of the Prov of BA, Axel Kicillof, announced today that the third dose of the vaccine against Covid-19 will be made available to all people over 18 years old. In addition, next Friday, between 8:00pm and midnight, there will be an exceptional inoculation day called "The Night of Vaccines" to facilitate attendance to 160 inoculation posts. The first of this campaign was held on Feb 4th....

 

[gracielle]

22 February 2022 by Pablo Sigal

Covid-19: el laboratorio argentino Raffo comercializará la vacuna de Moderna en el país

El acuerdo se firmó entre la empresa estadounidense y la latinoamericana Adium Pharma, que tendrá en Raffo su brazo local.

www.clarin.com

Covid-19: Argentine laboratory Raffo to market Moderna vaccine in the country. Moderna, which manufactures one of the two messenger RNA vaccines against Covid in the world market, signed an agreement granting a distribution license to the Latin American pharmaceutical company Adium Pharma, which will have the Raffo laboratory as its Argentine arm.

Adium Pharma S.A. is a Latin American company with presence in 11 countries in the region and headquarters in Uruguay. The agreement for the commercialization of the vaccine, whose name is Spikevax, covers 18 countries in Latin America, including Brazil, Mexico, Colombia and Argentina. The authorization of an Argentine representation for the product manufactured by Moderna could determine, for practical purposes, a speeding up of access in order to have in the country one of the vaccines that has shown the best results of efficacy against Covid....

 

[gracielle]

28 February 2022 by Helen Branswell, Senior Writer, Infectious Disease
Reprint from article published by The New York Times

Pfizer Covid vaccine is less effective in kids 5 to 11, study finds

New data suggest the Pfizer-BioNTech Covid vaccine works substantially less well at preventing infection and hospitalizations in kids 5 to 11.

www.statnews.com

 

[gracielle]

2 February 2022

Argentina no recibirá más vacunas de Rusia: el historial de los retrasos en las entregas y la carta de la polémica

Tras el anuncio de la ministra de Salud la Sputnik retrasada no llegará al país. Carla Vizzotti, destacada, Sputnik V

elintransigente.com

Argentina will no longer receive vaccines from Russia: the history of delivery delays and the letter of controversy....the Minister of Health, Carla Vizzotti, announced that our country will not ask Russia for the 9.5 million doses of Sputnik V of the current contract because they will be manufactured in the Richmond Laboratory in Pilar. She informed that the ANMAT (National Administration of Medicines, Food and Medical Technology) "has authorized the registration for emergency use by the Richmond Laboratory as the marketer of the Sputnik vaccine of the Russian Sovereign Investment Fund"....

 

[gracielle]

07 March 2022....Excerpt from the article by Ivan Ruiz with the collaboration of Sandra Crucianelli.

Qué pasará con los acuerdos que Argentina firmó con Rusia

Desde nueve millones de dosis de la vacuna Sputnik hasta un acuerdo cancelado por Aerolíneas Argentinas, cuál será el futuro de distintos convenios firmados durante el kirchnerismo con Vladimir Putin

www.infobae.com

....Although the concern about the level of inoculations is practically over in ARG, the agreement between the State and the Russian Investment Fund is still pending the purchase of 9M doses, that is to say, 33% of the contract. When asked by Infobae, the National Ministry of Health clarified that the money will be transferred when these vaccines are sent to Argentina and remarked that for now, with vaccination levels much higher than when the original agreement was signed, the doses are not necessary to complete the massive inoculation plan for Covid-19. "We have Pfizer and Moderna in stock; it is not a problem at the moment", clarified the Ministry of Health. The Russians should send the active ingredient to Richmond Laboratories, the pharmaceutical company in charge of the production of Sputnik V in ARG. People close to the company explained that, for the time being, those doses are not necessary because they have enough with what they received and that, in the event of needing to carry out sanitary exchanges or their consequent economic transfers, these would not be covered by the punishments against Russia since they are scientific-sanitary operations....